Finch Therapeutics Group, Inc. (FNCHQ) vs Silexion Therapeutics Corp (SLXN)

Finch Therapeutics Group, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Finch Therapeutics Group, Inc. and Silexion Therapeutics Corp are of similar size ($1.6M and $1.4M). Across the 8 metrics below, Finch Therapeutics Group, Inc. leads on 7 and Silexion Therapeutics Corp on 1.

Valuation

Metric FNCHQ SLXN Biotechnology median
P/E n/m n/m 7.88
P/S 27.07 n/m 11.47
P/B 1.17 4.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.04 0.74
EV/Sales 47.86 n/m 10.73
Earnings yield (85.22%) (8,359.54%) (28.84%)
Free cash flow yield (100.64%) (6,963.95%) (23.03%)

Profitability

Metric FNCHQ SLXN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (67.28%) (17,021.95%) (57.72%)
Return on assets (25.20%) (277.96%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FNCHQ SLXN Biotechnology median
Revenue growth (TTM) (96.00%) — 5.64%
EPS growth (last fiscal year) 35.36% 97.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FNCHQ SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.87 0.94 4.73
Net debt to EBITDA 0.31 0.38 0.96

Dividend

Metric FNCHQ SLXN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric FNCHQ SLXN Biotechnology median
Market cap 1.57m 1.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack